91 related articles for article (PubMed ID: 7313648)
1. [Hyperprolactinemia in the male: clinical aspects and therapy].
Eversmann T; Eichinger R; Fahlbusch R; Rjosk HK; von Werder K
Schweiz Med Wochenschr; 1981 Nov; 111(47):1782-9. PubMed ID: 7313648
[TBL] [Abstract][Full Text] [Related]
2. Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up.
Hildebrandt G; Bauer T; Stracke H; Fassbender WJ; Mueller HW; Agnoli AL; Federlin K; Roosen K
Zentralbl Neurochir; 1992; 53(3):123-34. PubMed ID: 1414079
[TBL] [Abstract][Full Text] [Related]
3. [Prolactin microadenoma in men. Study of 14 cases].
Gimenez-Roqueplo AP; Dupuy M; Delalande O; Visot A; Jedynak CP; Peillon F; Derome PJ
Ann Med Interne (Paris); 1992; 143(2):94-7. PubMed ID: 1530227
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
5. [Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
Abram F; Linke F; Kalfon A; Tchovelidze C; Chelbi N; Arvis G
Prog Urol; 1998 Sep; 8(4):537-41. PubMed ID: 9834517
[TBL] [Abstract][Full Text] [Related]
6. Treatment of patients with prolactinomas.
Werder Kv; Fahlbusch R; Landgraf R; Pickardt CR; Rjosk HK; Scriba PC
J Endocrinol Invest; 1978 Jan; 1(1):47-58. PubMed ID: 755842
[TBL] [Abstract][Full Text] [Related]
7. Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
[TBL] [Abstract][Full Text] [Related]
8. [The impact of prolactinoma in human reproduction].
Hurtado Amador R; Ayala AR; Hernández Marín I
Ginecol Obstet Mex; 2004 Jan; 72(1):3-9. PubMed ID: 15239558
[TBL] [Abstract][Full Text] [Related]
9. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia and sexual disorders in men.
Schwartz MF; Bauman JE; Masters WH
Biol Psychiatry; 1982 Aug; 17(8):861-76. PubMed ID: 7115837
[TBL] [Abstract][Full Text] [Related]
11. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine.
Thorner MO; Evans WS; MacLeod RM; Nunley WC; Rogol AD; Morris JL; Besser GM
Adv Biochem Psychopharmacol; 1980; 23():165-89. PubMed ID: 7395611
[No Abstract] [Full Text] [Related]
14. [Pregnancy in hyperprolactinemic patients].
Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
[TBL] [Abstract][Full Text] [Related]
15. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
16. Prolactin-secreting pituitary adenomas in males: transsphenoidal microsurgical treatment.
Serri O; Somma M; Rasio E; Beauregard H; Hardy J
Can Med Assoc J; 1980 May; 122(9):1007-13. PubMed ID: 7370879
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinaemia in males with and without pituitary macroadenomas.
Spark RF; Wills CA; O'Reilly G; Ransil BJ; Bergland R
Lancet; 1982 Jul; 2(8290):129-32. PubMed ID: 6123841
[TBL] [Abstract][Full Text] [Related]
18. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.
Franks S; Nabarro JD
Lancet; 1977 Apr; 1(8015):778-80. PubMed ID: 66572
[TBL] [Abstract][Full Text] [Related]
20. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
